22 results
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
, which (i) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
Settlement Date. The certificates for the Placement Shares, if any, will be made available by the Company for examination and packaging by the Agents … , or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any
6-K
EX-1.1
wjwfsomj6fv51
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-10.1
ou47dmwsx9bkaoh2rxd
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-1.1
06zh9i8agj
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
bphlb yjb
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
20-F/A
lxkk vwjgbuoq
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.1
suanyfl yx
19 Feb 19
Asset Purchase Agreement
4:57pm
6-K
EX-99.2
stpkof1p
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
rag9o5v mnd03wg
19 Nov 18
Agreement and Plan of Merger
4:34pm
20-F
j28hqp ap31r3l4dk
31 Mar 15
Annual report (foreign)
12:00am